2m 2m 2m 2m 2m 2m 2m
BIODESIX (BDSX)
NASDAQ
$23.93-$0.01 (-0.04%)
Price as of Oct 22, 2026 7:30 PM EDT- $252.5MMarket Cap
- 272.32%1-Year Change
- Diagnostics & ResearchIndustry
BIODESIX (BDSX)
$23.93-$0.01 (-0.04%)
BDSX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $23.94 | ||
Change | +$0.01 (+0.04%) | ||
Open | $23.76 | ||
High | $24.99 | ||
Low | $23.38 | ||
Previous Close | $23.93 | ||
Volume | 138,754 | ||
30-Day Average Volume | 96,905 | ||
1-Week Change | -3.12% | ||
1-Month Change | -14.96% | ||
1-Year Change | 272.32% | ||
3-Year Change | -30.00% | ||
5-Year Change | -84.43% | ||
Fundamentals | |||
Shares Outstanding | 10.6M | ||
Total Assets | $95.3M | ||
Market Cap | $252.5M | ||
Enterprise Value | $269.3M | ||
Period: QTR TTM FY | |||
Revenue | $26.9M | ||
Net Income | -$7.3M | ||
Free Cash Flow | -$1.8M | ||
EBIT | -$5.3M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $28.3M | ||
EPS | -$0.71 | ||
Enterprise Value/EBITDA | -69 | ||
Enterprise Value/Revenue | 10 | ||
P/B | 28 | ||
P/E | -34 | ||
PEG | -3 | ||
Price/Free Cash Flow | -144 | ||
Price/Operating Cash Flow | -162 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 09/15/2025 | ||
Earnings & Revenue